A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.

Trial Profile

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 28 Mar 2016

At a glance

  • Drugs Atacicept (Primary)
  • Indications Lupus nephritis; Systemic lupus erythematosus
  • Focus Registrational; Therapeutic Use
  • Sponsors EMD Serono
  • Most Recent Events

    • 15 Mar 2012 Company (Merck Serono) added as reported by European Clinical Trials Database record.
    • 25 Apr 2011 Planned end date changed from 1 Jun 2010 to 1 Mar 2009 as reported by ClinicalTrials.gov.
    • 25 Oct 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top